PDCT-09. TEMOZOLOMIDE WITH IRINOTECAN VERSUS TEMOZOLOMIDE, IRINOTECAN PLUS BEVACIZUMAB FOR RECURRENT MEDULLOBLASTOMA/CNS PNET OF CHILDHOOD: REPORT OF A COG RANDOMIZED PHASE II SCREENING TRIAL | Zendy

AI Assistant Blog Pricing

PDCT-09. TEMOZOLOMIDE WITH IRINOTECAN VERSUS TEMOZOLOMIDE, IRINOTECAN PLUS BEVACIZUMAB FOR RECURRENT MEDULLOBLASTOMA/CNS PNET OF CHILDHOOD: REPORT OF A COG RANDOMIZED PHASE II SCREENING TRIAL

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.